When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 14 Mar 2025
Last updated: 09 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • known diabetes
  • presence of risk factors

Other diagnostic factors

  • irritability
  • shakiness
  • sweating
  • tremor
  • palpitations
  • tachycardia
  • feeling warm
  • anxiety
  • nausea
  • hunger
  • pallor
  • higher blood glucose than usual on waking up
  • seizure
  • loss of consciousness
  • coma
  • confusion
  • problems with short-term memory
  • changes in vision
  • changes in speech
  • difficulty hearing
  • lethargy
  • drowsiness
  • quietness
  • tantrums
  • erratic behaviour
  • nightmares
  • headache
  • difficulty concentrating
  • dizziness
  • fall or motor vehicle accident
  • bedwetting

Risk factors

  • type 1 diabetes
  • antidiabetic drugs
  • age >60 years
  • age <6 years
  • poor glycaemic control
  • intensive glycaemic control efforts
  • previous severe (level 3) hypoglycaemia
  • previous clinically significant (level 2) hypoglycaemia
  • increased duration of diabetes
  • treatment with insulin >5 years
  • impaired cognitive function
  • impaired awareness of hypoglycaemia
  • first trimester of pregnancy
  • failure to thrive in children
  • poor oral intake
  • weight loss
  • malnutrition
  • sleep
  • hypoglycaemia-causing drugs (non-diabetic)
  • exercise
  • renal failure
  • liver failure
  • endocrine disorders
  • critical illness
  • alcohol ingestion

Diagnostic investigations

Treatment algorithm

Contributors

Authors

Guillermo Umpierrez, MD

Professor of Medicine

Emory University School of Medicine

Atlanta

GA

Disclosures

GU has received research grant support to Emory University from Dexcom, Abbott, and Bayer. Previous support was received from AstraZeneca.

Andrew Muir, MD

Marcus Professor of Pediatrics

Chief of Pediatric Endocrinology

Emory University School of Medicine

Atlanta

GA

Disclosures

AM has received research grant support to Emory University from the National Institute of Diabetes and Digestive and Kidney Diseases and Boehringer Ingelheim.

Khemaporn Lertdetkajorn, MD

Fellow

Emory University School of Medicine

Atlanta

GA

Disclosures

KL declares that she has no competing interests.

Peer reviewers

Kasia J. Lipska, MD, MHS

Associate Professor of Medicine

Yale School of Medicine

New Haven

CT

Disclosures

KJL receives grant support from the National Institutes of Health and other support from Centers for Medicare & Medicaid Services (CMS) to develop and evaluate publicly reported quality measures. KJL also receives royalties from UpToDate for writing and editing content.

Edward Jude, MD, MRCP

Consultant Physician and Diabetologist and Professor of Medicine

Tameside and Glossop Integrated Care NHS Foundation Trust

Ashton-under-Lyne

UK

Disclosures

EJ declares that he has no competing interests.

May Ng, OBE, PhD, MBA, LLM, MSc, MBBS, FRCPCH, FHEA, SFFMLM

Honorary Professor and Consultant Paediatric Endocrinologist

Southport and Ormskirk Hospital NHS Trust

Southport

UK

Disclosures

MN declares that she has no competing interests.

Use of this content is subject to our disclaimer